<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04006236</url>
  </required_header>
  <id_info>
    <org_study_id>AL33</org_study_id>
    <nct_id>NCT04006236</nct_id>
  </id_info>
  <brief_title>Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas</brief_title>
  <official_title>Growth and Tolerance of Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, controlled, double-blind, multicenter parallel study to evaluate the
      growth, tolerance and compliance of healthy infants fed infant formulas with extensively
      hydrolyzed casein protein.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 5, 2019</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight</measure>
    <time_frame>Day of Age (DOA) 14 to 119</time_frame>
    <description>Interval weight gain per day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length</measure>
    <time_frame>Study Day (SD) 1 to DOA 119</time_frame>
    <description>Interval length gain per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Head Circumference</measure>
    <time_frame>Study Day (SD) 1 to DOA 119</time_frame>
    <description>Interval HC gain per day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool Characteristics</measure>
    <time_frame>Study Day (SD) 1 to DOA 119</time_frame>
    <description>Parent Completed Diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Formula Intake</measure>
    <time_frame>Study Day (SD) 1 to DOA 119</time_frame>
    <description>Parent Completed Diary</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Infant Feeding and Stool Patterns Questionnaire</measure>
    <time_frame>Exit or DOA 119</time_frame>
    <description>Parent completed questionnaire; 16 questions with 5 categories scaled in the negative direction</description>
  </other_outcome>
  <other_outcome>
    <measure>Infant Behavior Questionnaire</measure>
    <time_frame>Exit or DOA 119</time_frame>
    <description>Parent completed questionnaire; 22 questions with 5 categories scaled in the negative direction</description>
  </other_outcome>
  <other_outcome>
    <measure>Formula Satisfaction Questionnaire</measure>
    <time_frame>Exit or DOA 119</time_frame>
    <description>Parent completed questionnaire; 13 questions of up to 5 categories scaled in the negative direction</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">198</enrollment>
  <condition>Infant Development</condition>
  <arm_group>
    <arm_group_label>Experimental Infant Formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>extensively hydrolyzed casein protein</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Infant Formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>extensively hydrolyzed casein protein</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental Infant Formula</intervention_name>
    <description>Feed Ad Libitum</description>
    <arm_group_label>Experimental Infant Formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control Infant Formula</intervention_name>
    <description>Feed Ad Libitum</description>
    <arm_group_label>Control Infant Formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant is judged to be in good health

          -  Participant is a singleton from a full-term birth with a gestational age of 37-42
             weeks

          -  Participant's birth weight was &gt; 2490 g (~5 lbs. 8 oz.)

          -  Parent(s) confirm their intention to feed their infant the study product as the sole
             source of nutrition for the duration of the study

          -  Parent(s) confirm their intention not to administer vitamins, minerals (with the
             exception of Vitamin D supplements), solid foods or juices to their infant from
             enrollment throughout the duration of the study

          -  Participant's parent(s) has voluntarily signed and dated an Informed Consent Form
             (ICF), approved by an Independent Ethics Committee/Institutional Review Board
             (IEC/IRB) and provided Health Insurance Portability and Accountability Act (HIPAA) (or
             other applicable privacy regulation) authorization

        Exclusion Criteria:

          -  An adverse maternal, fetal or participant medical history that is thought by the
             investigator to have potential for effects on tolerance, growth, and/or development.

          -  Participant is taking and plans to continue taking medications, home remedies,
             prebiotics, probiotics, herbal preparations or rehydration fluids that might affect
             gastrointestinal (GI) tolerance

          -  Participant participates in another study that has not been approved as a concomitant
             study by AN.

          -  Participant has an allergy or intolerance to any ingredient in the study product

          -  Participant has been treated with antibiotics within 1 week prior to enrollment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlett Ramirez</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kristen DeLuca, MS, RDN, LD</last_name>
    <phone>614-624-5455</phone>
    <email>kristen.deluca@abbott.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alabama Clinical Therapeutics, LLC</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>MedPharmics, LLC</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Watching Over Mothers &amp; Babies</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Paramount Research Solutions</name>
      <address>
        <city>College Park</city>
        <state>Georgia</state>
        <zip>30349</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Springs Medical Research</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MedPharmics, LLC</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MedPharmics, LLC</name>
      <address>
        <city>Gulfport</city>
        <state>Mississippi</state>
        <zip>30503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Quality Clinical Research Inc</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MedPharmics, LLC</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>PMG Research of Peidmont Healthcare</name>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <zip>28625</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Pediatric Associates of Fairfield, Inc.</name>
      <address>
        <city>Fairfield</city>
        <state>Ohio</state>
        <zip>45014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institute of Clinical Research, LLC</name>
      <address>
        <city>Mentor</city>
        <state>Ohio</state>
        <zip>44060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Cleveland Pediatric Research Center, LLC</name>
      <address>
        <city>Middleburg Heights</city>
        <state>Ohio</state>
        <zip>44130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Midsouth Center for Clinical Research</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38116</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ventavia Research Group, Llc</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ventavia Research Group</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77008</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ventavia Research Group, LLC</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>ClinPoint Trials</name>
      <address>
        <city>Waxahachie</city>
        <state>Texas</state>
        <zip>75165</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 1, 2019</study_first_submitted>
  <study_first_submitted_qc>July 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>July 9, 2020</last_update_submitted>
  <last_update_submitted_qc>July 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

